Phase 3 gMG Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Generalized Myasthenia GravisgMG

Alexion Pharmaceuticals, Inc.12 enrolled13 locationsNCT06607627

Recruiting

Phase 3

Zilucoplan for Severe gMG Exacerbations

Generalized Myasthenia Gravis (gMG)

Miriam Freimer15 enrolled1 locationNCT07215949